Pfizer, Inc. Stock

Equities

PFE

US7170811035

Pharmaceuticals

Market Closed - Nyse 16:02:25 2024-04-12 EDT 5-day change 1st Jan Change
25.86 USD -1.82% Intraday chart for Pfizer, Inc. -3.00% -10.18%
Sales 2024 * 60.02B 82.66B Sales 2025 * 62.6B 86.21B Capitalization 146B 202B
Net income 2024 * 6.92B 9.52B Net income 2025 * 9.43B 12.98B EV / Sales 2024 * 3.22 x
Net Debt 2024 * 47.04B 64.78B Net Debt 2025 * 41.91B 57.72B EV / Sales 2025 * 3.01 x
P/E ratio 2024 *
16.4 x
P/E ratio 2025 *
13.2 x
Employees 88,000
Yield 2024 *
7.15%
Yield 2025 *
7.46%
Free-Float 59.09%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.12%
1 week-3.00%
Current month-6.81%
1 month-7.68%
3 months-9.90%
6 months-21.45%
Current year-10.18%
More quotes
1 week
25.83
Extreme 25.83
27.42
1 month
25.83
Extreme 25.83
28.28
Current year
25.61
Extreme 25.61
30.28
1 year
25.61
Extreme 25.61
41.71
3 years
25.61
Extreme 25.61
61.71
5 years
25.61
Extreme 25.61
61.71
10 years
25.61
Extreme 25.61
61.71
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 92-12-31
Director of Finance/CFO 59 22-05-01
Chief Tech/Sci/R&D Officer - 19-06-30
Members of the board TitleAgeSince
Director/Board Member 66 20-03-31
Director/Board Member 64 17-02-22
Director/Board Member 60 13-09-26
More insiders
Date Price Change Volume
24-04-12 25.86 -1.82% 43,034,056
24-04-11 26.34 +0.08% 32,814,471
24-04-10 26.32 -1.72% 44,541,594
24-04-09 26.78 +0.75% 45,193,644
24-04-08 26.58 -0.30% 24,431,352

Delayed Quote Nyse, April 12, 2024 at 04:02 pm

More quotes
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
25.86 USD
Average target price
31.62 USD
Spread / Average Target
+22.27%
Consensus